ENvue Medical to Ring the Nasdaq Opening Bell on Wednesday, January 14th, 2026

Core Viewpoint - ENvue Medical, Inc. will ring the Nasdaq Opening Bell on January 14, 2026, marking a significant milestone for the company in the medical technology sector [1][3]. Company Overview - ENvue Medical, Inc. specializes in non-invasive therapeutic systems, including enteral access solutions and non-opioid pain management [1][4]. - The company is headquartered in Tyler, Texas, with research and development facilities in Tel-Aviv and Nesher, Israel [4]. Leadership and Ceremony Details - The ceremony will be led by Doron Besser, MD, the CEO of ENvue Medical, along with the leadership team, directors, employees, and key stakeholders [2][3]. - The event will take place at Nasdaq MarketSite in Times Square, New York, from 8:30 A.M. to 9:45 A.M. ET [3]. Technology Platforms - ENvue Medical operates two distinct technology platforms: the ENvue™ Navigation Platform and acoustic-based therapeutic technologies [4][5]. - The ENvue™ Navigation Platform is a minimally invasive electromagnetic navigation system for placing feeding tubes, which has received FDA 510(k) clearance for adult use [5]. - Acoustic-based technologies, such as PainShield® and UroShield®, utilize proprietary low-intensity surface acoustic wave technology for pain treatment and bacterial colonization reduction [5].